UBS believes that orders remain the focus of attention. The analyst reiterates his buy recommendation on the stock, but raises his price target to E1,050 (from E880), which represents a potential upside of +15%.

' ASML's sustained demand in the field of advanced technology motivates our Buy recommendation and an increase in the price target to 1,050 E' says UBS.

The important point is that the number of orders will be maintained when the results are published', says the research firm.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.